alexa Yi Feng
ISSN: 2167-7700

Chemotherapy: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Yi Feng

 Medical Oncology Department, Zhongshan Hospital, Fudan University, Fenglin Road 180#, Shanghai, China

 Yi Feng is currently working as associate professors at Medical Oncology Department, Zhongshan Hospital Fudan University, China. Yi Feng has extended her valuable service as oncologist has been a recipient of many award and grants. Her international experience includes various programs, contributions and participation in different countries for diverse fields of study. Her research interests reflect in her wide range of publications in various national and international journals. 

Research Interest

 Stem Cell Biology, Neuroendocrine Carcinoma, gastric cancer, Cell Biology, Cell Culture, PCR,


β-Tubulin is a Predictive Marker of Docetaxel Combined with S-1 in Recurrent or Metastatic Gastric Cancer

Yuehong Cui, Rongyuan Zhuang, Qian Li, Shan Yu, Yiyi Yu, Yi Feng, Yan Wang, Xi Guo and Tianshu Liu

Research Article: Chemotherapy (Los Angel) 2014, 3: 132

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version